Comparative Assessment of Garlina and Murraya koenigii L. in Alleviating Hyperlipidemia-induced Dysregulated Lipid Metabolism

Farzana Sadaf; Muhammad Azam; Syed Waleed Ahmed Bokhari; Sabiha Gul; Sumbul Shamim

doi:10.30621/jbachs.1693143

Comparative Assessment of Garlina and Murraya koenigii L. in Alleviating Hyperlipidemia-induced Dysregulated Lipid Metabolism

Abstract

Objective: This study aimed to evaluate the comparative assessment of Garlina and Murraya koenigii L. in hyperlipidemic rats. Material and Methods: In vivo antihyperlipidemic potential of different MURK (Murraya koenigii L.) extracts and Garlina was conducted on Wistar rats induced with high-cholesterol diet. All test samples were given at p.o. dosage of 50 mg/ kg and animals were observed for 60-days. Animal Food-intake and body weight along with lipid markers in liver and aorta were investigated. In addition to this, serum lipid biomarkers along with atherogenic index was also determined. The results compared with Atorvastatin treated group. Data is expressed as mean ± standard error mean (S.E.M) using ANOVA to determine significance. Results: MURK extracts significantly decreased body weight and food intake, in contrast to the Garlina and Atorvastatin groups. MURK-HEX (hexane) extract displayed the significant reduction of 3.83 ± 2.3 g in body weight. Similarly, MURK-hexane and MURK-EA (ethylacetate) also demonstrated the highest rate of reduction in food consumption, i.e., 65.62 ± 0.5 g and 64.61 ± 0.7 g respectively. Tissue levels of cholesterol and triacylglycerol (TAG) were measured in the liver and aorta. MURK-EA treated rats had the lowest liver cholesterol levels (130 mg/dl), while the group that received MURK-MeOH (methanol) had the lowest aortic cholesterol levels (120 mg/dl). Additionally, lower TAG levels in liver and aorta of MURK-MeOH treated group were observed, measuring 129 mg/dl and 139 mg/dl respectively. MURK-MeOH group also showed the lowest serum lipid markers, i.e., TAG, LDL, and cholesterol at 136, 144, and 48 mg/dl respectively. Further, the inverse relationship between atherogenicity index of plasma (AIP) and percent protection of treatment regime indicated that all treatment groups successfully control hyperlipidemia. Conclusion: Garlina and MURK extracts possess significant lipid lowering potential. Garlina enhanced the HDL serum levels and in turn, showed lowest AIP comparable to that of standard drug Atorvastatin.

Keywords

References

Balakumar P, Babbar L. Preconditioning the hyperlipidemic myocardium: fact or fantasy? Cell Signal. 2012;24(3):589-95.
Sudhakaran S, Bottiglieri T, Tecson KM, Kluger AY, McCullough PA, Bottlieri T. Alteration of lipid metabolism in chronic kidney disease, the role of novel antihyperlipidemic agents, and future directions. Rev Cardiovasc Med. 2018;19(3):77-88.
Basit A, Sabir S, Riaz M, Fawwad A. NDSP 05: Prevalence and pattern of dyslipidemia in urban and rural areas of Pakistan; a sub analysis from second National Diabetes Survey of Pakistan (NDSP) 2016–2017. Journal of Diabetes & Metabolic Disorders. 2020;19:1215-25.
Fatmi Z, Kondal D, Shivashankar R, Iqbal R, Khan AA, Mohan D, et al. Prevalence of dyslipidaemia and factors associated with dyslipidaemia among South Asian adults: The Center for Cardiometabolic Risk Reduction in South Asia Cohort Study. Natl Med J India. 2020;33(3).
Borén J, Williams KJ. The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis: a triumph of simplicity. Curr Opin Lipidol. 2016;27(5):473-83.
Galimberti F, Casula M, Olmastroni E. Apolipoprotein B compared with low-density lipoprotein cholesterol in the atherosclerotic cardiovascular diseases risk assessment. Pharmacol Res. 2023;195:106873.
Zhao Y, Yang Y, Xing R, Cui X, Xiao Y, Xie L, et al. Hyperlipidemia induces typical atherosclerosis development in Ldlr and Apoe deficient rats. Atherosclerosis. 2018;271:26-35.
Yu Q, Zheng H, Zhang Y. Inducible degrader of LDLR: A potential novel therapeutic target and emerging treatment for hyperlipidemia. Vascul Pharmacol. 2021;140:106878.

Yin R-X, Wu D-F, Miao L, Aung LHH, Cao X-L, Yan T-T, et al. Several genetic polymorphisms interact with overweight/obesity to influence serum lipid levels. Cardiovasc Diabetol. 2012;11(1):123.
Zhao X-N, Sun Q, Cao Y-Q, Ran X, Cao Y. Association between apolipoprotein gene polymorphisms and hyperlipidemia: a meta-analysis. BMC Genomic Data. 2021;22(1):14.
Sigudu TT, Mkhatshwa TN, Monyeki KD, Matshipi M. Associations between high cholesterol and insulin sensitivity in diabetic versus non-diabetic among young adults in Lephalale, Limpopo Province, South Africa. Front Endocrinol (Lausanne). 2025;16:1650989.
Sigudu TT, Mkhatshwa TN, Monyeki KD, Matshipi M. The role of triglycerides and HDL in predicting insulin resistance in diabetic and non-diabetic young adults in Lephalale, Limpopo Province, South Africa. Critical Public Health. 2025;35(1):2583607.
Vekic J, Stromsnes K, Mazzalai S, Zeljkovic A, Rizzo M, Gambini J. Oxidative stress, atherogenic dyslipidemia, and cardiovascular risk. Biomedicines. 2023;11(11):2897.
Li L, Guo Z, Zhao Y, Liang C, Zheng W, Tian W, et al. The impact of oxidative stress on abnormal lipid metabolism-mediated disease development. Arch Biochem Biophys. 2025:110348.
Wojdyło A, Oszmiański J, Czemerys R. Antioxidant activity and phenolic compounds in 32 selected herbs. Food Chem. 2007;105(3):940-49.
Balakrishnan R, Vijayraja D, Jo S-H, Ganesan P, Su-Kim I, Choi D-K. Medicinal profile, phytochemistry, and pharmacological activities of Murraya koenigii and its primary bioactive compounds. Antioxidants. 2020;9(2):101.
Pinto P, Cojandaraj L. Protective Effects of Murraya koenigii: Focus on Antihyperlipidemic Property. Curr Drug Ther. 2025;20(1):24-32.
Phatak RS, Khanwelkar CC, Matule SM, Datkhile KD, Hendre AS. Antihyperlipidemic activity of Murraya koenigii leaves methanolic and aqueous extracts on serum lipid profile of high fat-fructose fed rats. Pharmacognosy Journal. 2019;11(4).
Thakur MS, Deshmukh KN, Dey A, Ranjan D, Goyal A, Jachak SM. An alkaloid enriched fraction from Murraya koenigii (L.) Spreng. Leaves ameliorate HFD-induced obesity and metabolic complexities in C57BL/6J mice. J Ethnopharmacol. 2024;333:118423.
Mitra A, Mahadevappa M. Antidiabetic and hypolipidemic effects of mahanimbine (carbazole alkaloid) from Murraya koenigii (rutaceae) leaves. Int. J. Phytomedicine. 2010;2:22-30.
Gill NS, Sharma B. Study on antioxidant potential of Murraya koenigii leaves in Wistar rats. Pakistan Journal of Biological Sciences: PJBS. 2014;17(1):126-29.
Rehana D, Mahendiran D, Kumar RS, Rahiman AK. In vitro antioxidant and antidiabetic activities of zinc oxide nanoparticles synthesized using different plant extracts. Bioprocess Biosyst Eng. 2017;40(6):943-57.
Joshi T, Jain T, Mahar R, Singh SK, Srivastava P, Shukla SK, et al. Pyranocarbazoles from Murraya koenigii (L.) Spreng. as antimicrobial agents. Natural Product Research. 2018;32(4):430-34.
Qais FA, Shafiq A, Khan HM, Husain FM, Khan RA, Alenazi B, et al. Antibacterial effect of silver nanoparticles synthesized using Murraya koenigii (L.) against multidrug-resistant pathogens. Bioinorg Chem Appl. 2019;2019:4649506.
Husna F, Suyatna FD, Arozal W, Poerwaningsih EH. Anti-diabetic potential of Murraya koenigii (L.) and its antioxidant capacity in nicotinamide-streptozotocin induced diabetic rats. Drug Res. 2018;68(11):631-36.
Shah P, Singh S, Kumar A. Combined effect of hydroethanolic extracts of Murraya koenigii and Phyllanthus niruri leaves on paracetamol and ethanol-induced toxicity in HepG2 cell line. Curr Sci. 2015:1320-26.
Mahipal P, Pawar RS. Nephroprotective effect of Murraya koenigii on cyclophosphamide induced nephrotoxicity in rats. Asian Pac J Trop Med. 2017;10(8):808-12.
Arun A, Patel OP, Saini D, Yadav PP, Konwar R. Anti-colon cancer activity of Murraya koenigii leaves is due to constituent murrayazoline and O-methylmurrayamine A induced mTOR/AKT downregulation and mitochondrial apoptosis. Biomed Pharmacother. 2017;93:510-21.
Syam S, Abdul AB, Sukari MA, Mohan S, Abdelwahab SI, Wah TS. The growth suppressing effects of girinimbine on HepG2 involve induction of apoptosis and cell cycle arrest. Molecules. 2011;16(8):7155-70.
Xin Q, Muer A. Girinimbine inhibits the proliferation of human ovarian cancer cells in vitro via the phosphatidylinositol-3-kinase (PI3K)/akt and the mammalian target of rapamycin (mTOR) and Wnt/β-catenin signaling pathways. Medical science monitor: international medical journal of experimental and clinical research. 2018;24:5480.
Pei C, He Q, Liang S, Gong X. Mahanimbine exerts anticancer effects on human pancreatic cancer cells by triggering cell cycle arrest, apoptosis, and modulation of AKT/mammalian target of rapamycin (mTOR) and signal transducer and activator of transcription 3 (STAT3) signalling pathways. Medical science monitor: international medical journal of experimental and clinical research. 2018;24:6975.
Gupta S, George M, Singhal M, Sharma GN, Garg V. Leaves extract of Murraya Koenigii linn for anti-inflammatory and analgesic activity in animal models. J Adv Pharm Technol Res. 2010;1(1):68-77.
Khurana A, Sikha MS, Ramesh K, Venkatesh P, Godugu C. Modulation of cerulein‐induced pancreatic inflammation by hydroalcoholic extract of curry leaf (Murraya koenigii). Phytother Res. 2019;33(5):1510-25.
Birari R, Javia V, Bhutani KK. Antiobesity and lipid lowering effects of Murraya koenigii (L.) Spreng leaves extracts and mahanimbine on high fat diet induced obese rats. Fitoterapia. 2010;81(8):1129-33.
Hwerif N, Raghif A, Kadhim E. Effect of terpenes fraction of Iraqi cicer arietinum in experimentally induced hyperlipidemic mice. Int. J. Health Sci. 2022;6:10514-30.
Jan R, Khan M, Asaf S, Lubna, Asif S, Kim K-M. Bioactivity and therapeutic potential of kaempferol and quercetin: new insights for plant and human health. Plants. 2022;11(19):2623.
Zhang P, Liu N, Xue M, Zhang M, Xiao Z, Xu C, et al. β-Sitosterol reduces the content of triglyceride and cholesterol in a high-fat diet-induced non-alcoholic fatty liver disease zebrafish (Danio rerio) model. Animals. 2024;14(9):1289.
Balamurugan R, Stalin A, Aravinthan A, Kim J-H. γ-sitosterol a potent hypolipidemic agent: In silico docking analysis. Med Chem Res. 2015;24(1):124-30.
Buchineni M, Kudagi B, Mohan PR, Haritha M, Anjani DN. Hypolipidemic activity of Murraya koenigii in alloxan induced diabetic rats. The Pharma Innovation. 2016;5(5, Part B):101.
Nwaji AR. Antihyperlipidemic property of Murraya koenigii ethanolic leaf extract on lipid profile of rats fed with cholesterol-enriched diets. Niger J Physiol Sci. 2022;37(2):215-18.
Hendre A. Antihyperlipidemic activity of Murraya koenigii leaves methanolic and aqueous extracts on serum lipid profile of high fat-fructose fed rats. Pharmacognosy Journal. 2019;11:4,836-841.
Saravanan M, Pandikumar P, Prakash Babu N, Ignacimuthu S. Antihyperlipidemic activity of Ichnocarpus frutescens in triton WR-1339-induced and high-fat diet animals. Pharm Biol. 2011;49(10):1074-81.
Mollace V, Sacco I, Janda E, Malara C, Ventrice D, Colica C, et al. Hypolipemic and hypoglycaemic activity of bergamot polyphenols: from animal models to human studies. Fitoterapia. 2011;82(3):309-16.
Chaudhari HS, Bhandari U, Khanna G. Preventive effect of embelin from embelia ribes on lipid metabolism and oxidative stress in high-fat diet-induced obesity in rats. Planta Med. 2012;78(07):651-57.
Shivaprasad HN, Gopalakrishna S, Mariyanna B, Thekkoot M, Reddy R, Tippeswamy BS. Effect of Coleus forskohlii extract on cafeteria diet-induced obesity in rats. Pharmacognosy Res. 2014;6(1):42.
Sarega N, Imam MU, Esa NM, Zawawi N, Ismail M. Effects of phenolic-rich extracts of Clinacanthus nutans on high fat and high cholesterol diet-induced insulin resistance. BMC Complement Altern Med. 2016;16:1-11.
Lai P, Du J-R, Zhang M-X, Kuang X, Li Y-J, Chen Y-S, et al. Aqueous extract of Gleditsia sinensis Lam. fruits improves serum and liver lipid profiles and attenuates atherosclerosis in rabbits fed a high-fat diet. J Ethnopharmacol. 2011;137(3):1061-66.
Ntchapda F, Maguirgue K, Adjia H, Etet PFS, Dimo T. Hypolipidemic, antioxidant and anti—atherosclerogenic effects of aqueous extract of Zanthoxylum heitzii stem bark in diet—induced hypercholesterolemic rats. Asian Pac J Trop Med. 2015;8(5):359-65.
Kumar R, Arora V, Ram V, Bhandari A, Vyas P. Hypoglycemic and hypolipidemic effect of Allopolyherbal formulations in streptozotocin induced diabetes mellitus in rats. Int J Diabetes Mellit. 2015;3(1):45-50.
Dobiášová M, Frohlich J, Šedová M, Cheung MC, Brown BG. Cholesterol esterification and atherogenic index of plasma correlate with lipoprotein size and findings on coronary angiography. J Lipid Res. 2011;52(3):566-71.
Chikezie CM, Ojiako OA, Emejulu AA, Chikezie PC. Atherogenicity of diabetic rats administered single and combinatorial herbal extracts. Bulletin of Faculty of Pharmacy, Cairo University. 2018;56(2):169-74.
Singh T, Sharma L, Patel P, Kurmi BD. Exploring the Relationship between Cholesterol Synthesis and Vitamin D: Implications and Insight. International Journal of Newgen Research in Pharmacy & Healthcare. 2024:42-50.
Zhao R, Tang Y, Cao W, Zhao L, Wu Z, Chen X, et al. Identification of multiple plasma lipids as diagnostic biomarkers of hypercholesterolemia and the underlying mechanisms based on pseudo‐targeted lipidomics. Rapid Commun Mass Spectrom. 2024;38(9):e9723.
Luna-Castillo KP, Olivares-Ochoa XC, Hernández-Ruiz RG, Llamas-Covarrubias IM, Rodríguez-Reyes SC, Betancourt-Núñez A, et al. The effect of dietary interventions on hypertriglyceridemia: from public health to molecular nutrition evidence. Nutrients. 2022;14(5):1104.
Zou P, Wang L. Dietary pattern and hepatic lipid metabolism. Liver Research. 2023; 7(4):275-284.
Song Z, Xiaoli AM, Yang F. Regulation and metabolic significance of de novo lipogenesis in adipose tissues. Nutrients. 2018;10(10):1383.
Parmar RM, Can AS. Physiology, appetite and weight regulation. 2021.
Vrânceanu M, Hegheş S-C, Cozma-Petruţ A, Banc R, Stroia CM, Raischi V, et al. Plant-derived nutraceuticals involved in body weight control by modulating gene expression. Plants. 2023;12(12):2273.
Tutunchi H, Arefhosseini S, Nomi-Golzar S, Ebrahimi-Mameghani M. Effects of Hydroxycitric Acid Supplementation on Body Composition, Obesity Indices, Appetite, Leptin, and Adiponectin of Women with NAFLD on a Calorie‐Restricted Diet. Int J Clin Pract. 2023;2023(1):6492478.
Zheng S, Tsao PS, Pan C. Abdominal aortic aneurysm and cardiometabolic traits share strong genetic susceptibility to lipid metabolism and inflammation. Nature communications. 2024;15(1):5652.
Geisler CE, Renquist BJ. Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones. J Endocrinol. 2017;234(1):R1-R21.
Hermida N, Balligand J-L. Low-density lipoprotein-cholesterol-induced endothelial dysfunction and oxidative stress: the role of statins. Antioxidants & redox signaling. 2014;20(8):1216-37.
Mundi S, Massaro M, Scoditti E, Carluccio MA, Van Hinsbergh VW, Iruela-Arispe ML, et al. Endothelial permeability, LDL deposition, and cardiovascular risk factors—A review. Cardiovasc Res. 2018;114(1):35-52.
Yu X-H, Fu Y-C, Zhang D-W, Yin K, Tang C-K. Foam cells in atherosclerosis. Clin Chim Acta. 2013;424:245-52.
Allahverdian S, Chehroudi AC, McManus BM, Abraham T, Francis GA. Contribution of intimal smooth muscle cells to cholesterol accumulation and macrophage-like cells in human atherosclerosis. Circulation. 2014;129(15):1551-59.
Stary HC, Chandler AB, Glagov S, Guyton JR, Insull Jr W, Rosenfeld ME, et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation. 1994;89(5):2462-78.
Jebari-Benslaiman S, Galicia-García U, Larrea-Sebal A, Olaetxea JR, Alloza I, Vandenbroeck K, et al. Pathophysiology of atherosclerosis. Int J Mol Sci. 2022;23(6):3346.
Wang HH, Garruti G, Liu M, Portincasa P, Wang DQ. Cholesterol and lipoprotein metabolism and atherosclerosis: recent advances in reverse cholesterol transport. Ann Hepatol. 2018;16(1):27-42.
Sacks FM, Lichtenstein AH, Wu JH, Appel LJ, Creager MA, Kris-Etherton PM, et al. Dietary fats and cardiovascular disease: a presidential advisory from the American Heart Association. Circulation. 2017;136(3):e1-e23.
Karney A, Brągoszewska H, Soluch L, Ołtarzewski M. Risk factors for atherosclerosis in obese children aged 6-12 years. Developmental Period Medicine. 2017;21(3):259-65.
Mirzadeh M, Nikparvar M, Rafati S, Kheirandish M, Azarbad A, Sheybani-Arani M, et al. Atherogenic index of plasma as a predictor of coronary artery disease: a cohort study in south of Iran. The Egyptian Heart Journal. 2024;76(1):65.
Feingold KR. Introduction to lipids and lipoproteins. Endotext [internet]. 2024.
von Eckardstein A, Nordestgaard BG, Remaley AT, Catapano AL. High-density lipoprotein revisited: biological functions and clinical relevance. Eur Heart J. 2023;44(16):1394-407.
Hill CR, Haoci Liu A, McCahon L, Zhong L, Shafaei A, Balmer L, et al. S-methyl cysteine sulfoxide and its potential role in human health: a scoping review. Crit Rev Food Sci Nutr. 2023:1-14.
Sleiman C, Daou R-M, Al Hazzouri A, Hamdan Z, Ghadieh HE, Harbieh B, et al. Garlic and hypertension: efficacy, mechanism of action, and clinical implications. Nutrients. 2024;16(17):2895.
Ravi Y, Vethamoni IP, Saxena SN, Velmurugan S, Santanakrishnan V, Raveendran M, et al. Guesstimate of thymoquinone diversity in Nigella sativa L. genotypes and elite varieties collected from Indian states using HPTLC technique. Open Life Sciences. 2023;18(1):20220536.
Abbas M, Gururani MA, Ali A, Bajwa S, Hassan R, Batool SW, et al. Antimicrobial Properties and Therapeutic Potential of Bioactive Compounds in Nigella sativa: A Review. Molecules. 2024;29(20):4914.
Yang Y, Sun X, Peng C, Wei J, Yang X. The Genus Commiphora: An Overview of Its Traditional Uses, Phytochemistry, Pharmacology, and Quality Control. Pharmaceuticals. 2024;17(11):1524.
Sulejmanović M, Panić M, Redovniković IR, Milić N, Drljača J, Damjanović A, et al. Sustainable isolation of ginger (Zingiber officinale) herbal dust bioactive compounds with favorable toxicological profile employing natural deep eutectic solvents (NADES). Food Chem. 2025;464:141545.
Gorrepati K, Krishna R, Singh S, Shirsat DV, Soumia P, Mahajan V. Harnessing the nutraceutical and therapeutic potential of Allium spp.: current insights and future directions. Frontiers in Nutrition. 2024;11:1497953.
Derosa G, D’Angelo A, Maffioli P, Cucinella L, Nappi RE. The Use of Nigella sativa in Cardiometabolic Diseases. Biomedicines. 2024;12(2):405.
Salaramoli S, Mehri S, Yarmohammadi F, Hashemy SI, Hosseinzadeh H. The effects of ginger and its constituents in the prevention of metabolic syndrome: A review. Iran J Basic Med Sci. 2022;25(6):664.
Habib N, Choudhry S. HPLC quantification of thymoquinone extracted from Nigella sativa L.(Ranunculaceae) seeds and antibacterial activity of its extracts against Bacillus species. Evidence‐Based Complementary and Alternative Medicine. 2021;2021(1):6645680.

Details

Primary Language

English

Subjects

Medical Biochemistry - Lipids, Molecular Medicine

Journal Section

Research Article

Authors

Farzana Sadaf
0000-0001-7258-9174
Pakistan

Muhammad Azam ^*
0000-0001-7340-0396
Pakistan

Syed Waleed Ahmed Bokhari
0000-0003-3135-6934
Czech Republic

Sabiha Gul
0000-0002-0289-5392
Italy

Sumbul Shamim
0000-0002-3248-6717
Pakistan

Publication Date

September 30, 2026

Submission Date

May 9, 2025

Acceptance Date

August 5, 2026

Published in Issue

Year 2026 Volume: 10 Number: 3

DOI

https://doi.org/10.30621/jbachs.1693143

IZ

https://izlik.org/JA33PG73LU

Cite

RIS / Bibtex

APA

Sadaf, F., Azam, M., Bokhari, S. W. A., Gul, S., & Shamim, S. (2026). Comparative Assessment of Garlina and Murraya koenigii L. in Alleviating Hyperlipidemia-induced Dysregulated Lipid Metabolism. Journal of Basic and Clinical Health Sciences, 10(3), 305-317. https://doi.org/10.30621/jbachs.1693143

AMA

1.Sadaf F, Azam M, Bokhari SWA, Gul S, Shamim S. Comparative Assessment of Garlina and Murraya koenigii L. in Alleviating Hyperlipidemia-induced Dysregulated Lipid Metabolism. JBACHS. 2026;10(3):305-317. doi:10.30621/jbachs.1693143

Chicago

Sadaf, Farzana, Muhammad Azam, Syed Waleed Ahmed Bokhari, Sabiha Gul, and Sumbul Shamim. 2026. “Comparative Assessment of Garlina and Murraya Koenigii L. In Alleviating Hyperlipidemia-Induced Dysregulated Lipid Metabolism”. Journal of Basic and Clinical Health Sciences 10 (3): 305-17. https://doi.org/10.30621/jbachs.1693143.

EndNote

Sadaf F, Azam M, Bokhari SWA, Gul S, Shamim S (September 1, 2026) Comparative Assessment of Garlina and Murraya koenigii L. in Alleviating Hyperlipidemia-induced Dysregulated Lipid Metabolism. Journal of Basic and Clinical Health Sciences 10 3 305–317.

IEEE

[1]F. Sadaf, M. Azam, S. W. A. Bokhari, S. Gul, and S. Shamim, “Comparative Assessment of Garlina and Murraya koenigii L. in Alleviating Hyperlipidemia-induced Dysregulated Lipid Metabolism”, JBACHS, vol. 10, no. 3, pp. 305–317, Sept. 2026, doi: 10.30621/jbachs.1693143.

ISNAD

Sadaf, Farzana - Azam, Muhammad - Bokhari, Syed Waleed Ahmed - Gul, Sabiha - Shamim, Sumbul. “Comparative Assessment of Garlina and Murraya Koenigii L. In Alleviating Hyperlipidemia-Induced Dysregulated Lipid Metabolism”. Journal of Basic and Clinical Health Sciences 10/3 (September 1, 2026): 305-317. https://doi.org/10.30621/jbachs.1693143.

JAMA

1.Sadaf F, Azam M, Bokhari SWA, Gul S, Shamim S. Comparative Assessment of Garlina and Murraya koenigii L. in Alleviating Hyperlipidemia-induced Dysregulated Lipid Metabolism. JBACHS. 2026;10:305–317.

MLA

Sadaf, Farzana, et al. “Comparative Assessment of Garlina and Murraya Koenigii L. In Alleviating Hyperlipidemia-Induced Dysregulated Lipid Metabolism”. Journal of Basic and Clinical Health Sciences, vol. 10, no. 3, Sept. 2026, pp. 305-17, doi:10.30621/jbachs.1693143.

Vancouver

1.Farzana Sadaf, Muhammad Azam, Syed Waleed Ahmed Bokhari, Sabiha Gul, Sumbul Shamim. Comparative Assessment of Garlina and Murraya koenigii L. in Alleviating Hyperlipidemia-induced Dysregulated Lipid Metabolism. JBACHS. 2026 Sep. 1;10(3):305-17. doi:10.30621/jbachs.1693143